BioNTech SE

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.

About BNTX

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.

CEO

Ugur Sahin

CEOUgur Sahin

Employees

6,772

Employees6,772

Headquarters

Mainz, Rheinland-Pfalz

HeadquartersMainz, Rheinland-Pfalz

Founded

2008

Founded2008

Employees

6,772

Employees6,772

BNTX Key Statistics

Market cap

27.89B

Market cap27.89B

Price-Earnings ratio

-33.09

Price-Earnings ratio-33.09

Dividend yield

—

Dividend yield—

Average volume

1.31M

Average volume1.31M

High today

$126.03

High today$126.03

Low today

$115.61

Low today$115.61

Open price

$120.88

Open price$120.88

Volume

2.59M

Volume2.59M

52 Week high

$131.49

52 Week high$131.49

52 Week low

$76.53

52 Week low$76.53

BNTX News

Simply Wall St 1h

Bristol-Myers Squibb Collaborates With BioNTech For Antibody Development In Cancer Treatment

recently announced a significant partnership with BioNTech SE to co-develop and co-commercialize the bispecific antibody BNT327, targeting multiple solid tumor...

Analyst ratings

72%

of 25 ratings

Buy

72%

Hold

28%

Sell